Stockreport

Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF As the first AP Rated Generic to Dr. Reddy's, this product provides healthcare providers with a critical chemotherapy medication that slows the growth of cancer cells. [Read more]